Hamilton Depression Rating Scale (HAM-D)

The Hamilton Depression Rating Scale (HAM‑D) is a clinician‑rated tool that quantifies the severity of depressive symptoms.

Depressed mood
Absent0Sadness+1Occasional weeping+2Frequent weeping+3Extreme weeping+4
Feelings of guilt
Absent0Self-reproach, feels he/she has let people down+1Ideas of guilt+2Present illness is a punishment, delsions of guilt+3Hallucinations of guilt+4
Suicide
Absent0Feels life is not worth living+1Wishes he/she were dead+2Suicidal ideas or gestures+3Attempts at suicide+4
Initial Insomnia
Absent0Occasional+1Frequent+2
Insomnia during the night
Absent0Occasional+1Frequent+2
Delayed Insomnia
Absent0Occasional+1Frequent+2
Work Interests
No difficulty0Feelings of incapacity, listlessness, indecision, and vacillation+1Loss of interest in hobbies, decreased social activities+2Productivity decreased+3Unable to work, stopped working because of present illness only+4
Retardation
Absent0Slight retardation at interview+1Obvious retardation at interview+2Interview difficult+3Complete stupor+4
Agitation
Absent0Mild+1Severe+2
Psychiatric anxeity
Absent0Tension and irritability+1Worrying about minor matters+2Apprehensive attitude+3Fears+4
Somatic anxiety
Absent0Mild+1Moderate+2Severe+3Incapacitating+4
Gastrointestinal somatic symptoms
Absent0Mild+1Severe+2
General somatic symptoms
Absent0Mild+1Severe+2
Genital Symptoms
Absent0Mild+1Severe+2
Hypochondriasis
Not present0Bodily self-absorption+1Preoccupation with health+2Querulous attitude+3Hypochondriacal delusions+4
Weight loss
None0Slight+1Obvious or severe+2
Insight
No Loss0Partial or doubtful+1Loss of insight+2

Indications d'utilisation

Used to assess clinician-rated depressive severity, track treatment response, and define response/remission thresholds (e.g., remission ≤7) in major depression 1 [Level I evidence]. Highly utilized in trials (≈40% of depression RCTs) for standardized outcome measurement 2 [Level I evidence]. Structured and abbreviated versions (e.g., HAM-D6) improve scalability and responsiveness for monitoring change 3 [Level II evidence].

Informations et précautions

Captures core depressive symptoms but misses ~41% of patient‑important domains in trials 1 [Level I evidence]. Structured versions improve reliability, while unstructured formats perform poorly 2 [Level III evidence]. Multidimensionality limits interpretability, and several items show weak psychometrics 3 [Level II evidence]. The HAM‑D6 is more sensitive and scalable than HAM‑D17 for treatment effects 4 [Level I evidence].